Table 4. Distribution of Treatment Modalities by Organisms.

	Surgical Treatment
Organism	Ex Situ	Excision	Flap	I&D	In Situ	In Situ and Flap	Total
MRSA	2 (20.0%)	3 (30.0%)	1 (10.0%)	2 (20.0%)	0	2 (20.0%)	10 (100.0%)
S. epidermidis	1 (9.1%)	4 (36.4%)	4 (36.4%)	0	1 (9.1%)	1 (9.1%)	11 (100.0%)
Gram-negative organisms	3 (21.4%)	2 (14.3%)	7 (50.0%)	2 (14.3%)	0	0	14 (100.0%)
No growth	0	2 (28.6%)	2 (28.6%)	3 (42.9%)	0	0	7 (100.0%)
Total	6 (14.3%)	11 (26.2%)	14 (33.3%)	7 (16.7%)	1 (2.4%)	3 (7.1%)	42 (100.0%)

Data are count (% within organism).

I & D, irrigation and debridement; MRSA, methicillin-resistant Staphylococcus aureus.